P&C PRODUCTS · 66-41 · ITALY
For P&C PRODUCTS · 66-41 · ITALY, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is ITALY; product is Neoprosone-Gel Forte | Neoprosone-Gel Forte; product code is 64 L - - 67 Clobetasol Propionate (Glucocorticoid) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 10/01/2021; address is Largo Desio , Milan, Milan ITALY, verified against its source on 2026-09-16.
- Firm
- P&C PRODUCTS verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- ITALY verified
- Address
- Largo Desio , Milan, Milan ITALY verified
- Date published
- 10/01/2021 verified
- Product code
- 64 L - - 67 Clobetasol Propionate (Glucocorticoid) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Neoprosone-Gel Forte | Neoprosone-Gel Forte each item verified
- FDA notes
- The product appears to be an unapproved new drug as the product’s informational insert includes claims such as (not an all-inclusive list): ‘is a pharmaceutical product effective against acute dermatitis: eczema, psoriasis, itchiness, local inflammations and allergic reactions…’. | The product appears to be an unapproved new drug as the product’s informational insert includes claims such as (not an all-inclusive list): ‘is a pharmaceutical product effective against acute dermatitis: eczema, psoriasis, itchiness, local inflammations and allergic reactions…’. each item verified
What the source says
P&C PRODUCTS Date Published : 10/01/2021 Largo Desio , Milan, Milan ITALY 64 L - - 67 Clobetasol Propionate (Glucocorticoid) Date Published: 10/01/2021 Desc: Neoprosone-Gel Forte Notes: The product appears to be an unapproved new drug as the product’s informational insert includes claims such as (not an all-inclusive list): ‘is a pharmaceutical product effective against acute dermatitis: eczema, psoriasis, itchiness, local inflammations and allergic reactions…’. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 10/01/2021 Desc: Neoprosone-Gel Forte Notes: The product appears to be an unapproved new drug as the product’s informational insert includes claims such as (not an all-inclusive list): ‘is a pharmaceutical product effective against acute dermatitis: eczema, psoriasis, itchiness, local inflammations and allergic reactions…’.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.